FindTrial
Sign In

A Community Based Study to determine the burden of fever cases with focus on Dengue & Chikungunya infections

Community Based Surveillance to Estimate Incidence & Sero prevalence of Acute Febrile Illness with focus on Dengue & Chikungunya â?? A Prospective Multi-centric Cohort Study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/06/053781
Enrollment
750
Registered
2023-06-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: NIL: NIL

Sponsors

SHARE INDIA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Study will be carried out in individuals above 2 Years of age. 2.Individuals currently residing and likely to stay till the end of one year in the study area. 3.Consented to participate in both sections of the study (Sero Prevalence and AFI Surveillance) and follow all study procedures.

Exclusion criteria

Exclusion criteria: Ongoing fever episodes or history of AFI on or within 3 calendar days before enrolment for the cohort

Design outcomes

Primary

MeasureTime frame
The primary outcome is estimation of the burden of diseases causing acute febrile illness with focus on Dengue & Chikungunya at community level & determine the seasonal variations and the rate of transmission in the incidence of acute febrile illnessesTimepoint: Baseline and at the end of 12 months—

Secondary

MeasureTime frame
1.The identification of groups who are most vulnerable to Dengue & Chikungunya infection (e.g. age groups, gender, occupation) 2.The sensitivity and specificity of IgG ELISA will be calculated against PRNT (Neutralizing antibodies). 3.The cost of illness of a case of dengue fever, chikungunya fever and dengue hemorrhagic fever will be calculated for both hospitalized and ambulatory cases Timepoint: all secondary outcomes will be assessed at the end of one year from baseline—

Countries

India

Contacts

Public ContactD Shailendra

MediCiti Institute of Medical Sciences

shailendra962@gmail.com9849145768

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026